Homepage
Open in app
Sign inGet started

AlbionVC Publication

Venture capital firm investing from late seed to Series B in B2B software, deeptech and healthcare in the UK.

  • About
  • Subscribe to Newsletter
  • HealthTech primer for Europe: Our thoughts on the state and future of technology in European…

    HealthTech primer for Europe: Our thoughts on the state and future of technology in European…

    Throughout 2020 and 2021, healthcare has been at the forefront of almost every agenda: public and private, company and government, young…
    Go to the profile of Christoph Ruedig
    Christoph Ruedig
    Sep 9, 2021
    Our journey with Oviva: seed to Series C

    Our journey with Oviva: seed to Series C

    Today, AlbionVC portfolio company Oviva announced that they raised $80m in a Series C funding round co-led by Sofina and Temasek…
    Go to the profile of Christoph Ruedig
    Christoph Ruedig
    Aug 31, 2021
    Why we invested in Gravitee.io

    Why we invested in Gravitee.io

    We are delighted to announce that we have co-led an $11m series A round in Gravitee.io, an exciting open source API management platform.
    Go to the profile of Paul Lehair
    Paul Lehair
    Jul 22, 2021
    A masterclass in media relations: how to get press for your startup

    A masterclass in media relations: how to get press for your startup

    Earlier in June James Cook, special correspondent and technology reporter at The Telegraph spoke to AlbionVC portfolio companies about…
    Go to the profile of AlbionVC
    AlbionVC
    Jun 29, 2021
    Talent & people
    Want to make your company more investable?

    Want to make your company more investable?

    Hiring well is more than a catalyst for growth. It’s a foundational capability which enables a company to succeed. It underpins a…
    Go to the profile of Jane Elizabeth Reddin
    Jane Elizabeth Reddin
    Jun 24, 2021
    The leadership checklist: what founders need to analyse and improve their leadership potential

    The leadership checklist: what founders need to analyse and improve their leadership potential

    Leadership. We know the word, we recognise it in action, but do we really understand the mechanics? When it comes to scaling start-ups…
    Go to the profile of Jane Elizabeth Reddin
    Jane Elizabeth Reddin
    Feb 16, 2021
    The Trust Index: How Series A founders can develop a cohesive team

    The Trust Index: How Series A founders can develop a cohesive team

    How difficult would it be to work with someone you don’t trust? I’ve asked this question at interviews for 25 years and despite the…
    Go to the profile of Jane Elizabeth Reddin
    Jane Elizabeth Reddin
    Apr 22, 2021
    Workplace Culture during the pandemic | AlbionVC

    Workplace Culture during the pandemic | AlbionVC

    Last year we published a study together with Fenji & Co, highlighting the importance of company culture on a firm’s ability to scale. In…
    Go to the profile of Ed Lascelles
    Ed Lascelles
    Jun 5, 2020
    Why we invested in
    Why we invested in NuvoAir

    Why we invested in NuvoAir

    The Covid-19 pandemic provides a unique opportunity to reshape healthcare delivery as we know it. As health systems were forced to deliver…
    Go to the profile of Jessica Bartos
    Jessica Bartos
    Jun 22, 2021
    Why we invested in Accelex | AlbionVC

    Why we invested in Accelex | AlbionVC

    Every quarter we embark on a portfolio valuation exercise which entails haranguing the CFOs of over 50 portfolio companies for the latest…
    Go to the profile of Jay Wilson
    Jay Wilson
    May 25, 2021
    Why we are doubling down on Healios!

    Why we are doubling down on Healios!

    AlbionVC has been investing in healthcare services for 20 years and in digital health for more than 10. Over the past decade, we have seen…
    Go to the profile of Cat McDonald
    Cat McDonald
    May 18, 2021
    Why we invested in Solidatus | AlbionVC

    Why we invested in Solidatus | AlbionVC

    Data is exploding on every dimension: volume, complexity, cost, and risk and data models are changing frequently. Organisations are today…
    Go to the profile of Jay Wilson
    Jay Wilson
    Feb 11, 2021
    Why we invested in uMed | AlbionVC

    Why we invested in uMed | AlbionVC

    As the world collectively celebrates the announcement of Covid-19 vaccines from Pfizer/BioNTech, Moderna and others, clinical trials are…
    Go to the profile of Jessica Bartos
    Jessica Bartos
    Dec 1, 2020
    About AlbionVC PublicationLatest StoriesArchiveAbout MediumTermsPrivacyTeams